Home
>
National Drug Code (NDC)
>
Topical Anesthetic
Topical Anesthetic - 50227-2116-1 - (Benzocaine)
Drug Information of Topical Anesthetic
| Product NDC: | 50227-2116 |
| Proprietary Name: | Topical Anesthetic |
| Non Proprietary Name: | Benzocaine |
| Active Ingredient(s): | 220 mg/g & nbsp; Benzocaine |
| Administration Route(s): | DENTAL |
| Dosage Form(s): | GEL, DENTIFRICE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Topical Anesthetic
| Product NDC: | 50227-2116 |
| Labeler Name: | Patterson Dental |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | part356 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 19630219 |
Package Information of Topical Anesthetic
| Package NDC: | 50227-2116-1 |
| Package Description: | 34 g in 1 JAR (50227-2116-1) |
NDC Information of Topical Anesthetic
| NDC Code | 50227-2116-1 |
| Proprietary Name | Topical Anesthetic |
| Package Description | 34 g in 1 JAR (50227-2116-1) |
| Product NDC | 50227-2116 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benzocaine |
| Dosage Form Name | GEL, DENTIFRICE |
| Route Name | DENTAL |
| Start Marketing Date | 19630219 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Patterson Dental |
| Substance Name | BENZOCAINE |
| Strength Number | 220 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient] |
